APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ophthalmic AI-assisted Diagnosis Solution

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ophthalmic AI-assisted Diagnosis Solution Market Analysis and Forecast 2026-2032

6 March 2026191 pages

Choose your research edition.

Industry ResearchOphthalmic AI-assisted Diagnosis Solution Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Ophthalmic AI-assisted Diagnosis Solution Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Ophthalmic AI-assisted Diagnosis Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ophthalmic AI-assisted Diagnosis Solution Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Ophthalmic AI-assisted Diagnosis Solution Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Ophthalmic AI-assisted Diagnosis Solution market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Ophthalmic AI-assisted Diagnosis Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ophthalmic AI-assisted Diagnosis Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ophthalmic AI-assisted Diagnosis Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ophthalmic AI-assisted Diagnosis Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Ophthalmic AI-assisted Diagnosis Solution include Baidu Lingyi, Tencent Health, VoxelCloud, Wision, ZHENHEALTH, Acer Medical, IMLINCS, Vistel and Airdoc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Ophthalmic AI-assisted Diagnosis Solution, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ophthalmic AI-assisted Diagnosis Solution, also provides the revenue of main regions and countries. Of the upcoming market potential for Ophthalmic AI-assisted Diagnosis Solution, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ophthalmic AI-assisted Diagnosis Solution revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ophthalmic AI-assisted Diagnosis Solution market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Ophthalmic AI-assisted Diagnosis Solution revenue, projected growth trends, production technology, application and end-user industry.

Ophthalmic AI-assisted Diagnosis Solution Segment by Company

Baidu Lingyi

Tencent Health

VoxelCloud

Wision

ZHENHEALTH

Acer Medical

IMLINCS

Vistel

Airdoc

Shenzhen SiSensing

WeDoctor

Altris, Inc

Ophthalmic AI-assisted Diagnosis Solution Segment by Type

Cloud-based

On-Primes

Ophthalmic AI-assisted Diagnosis Solution Segment by Application

Hospital

Clinic

Imaging Center

Ophthalmic AI-assisted Diagnosis Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic AI-assisted Diagnosis Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic AI-assisted Diagnosis Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic AI-assisted Diagnosis Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Ophthalmic AI-assisted Diagnosis Solution in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Ophthalmic AI-assisted Diagnosis Solution company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ophthalmic AI-assisted Diagnosis Solution revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ophthalmic AI-assisted Diagnosis Solution Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cloud-based Major Player Table 3. On-Primes Major Player Table 4. Global Ophthalmic AI-assisted Diagnosis Solution Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. Imaging Center Major Player Table 8. Ophthalmic AI-assisted Diagnosis Solution Industry Trends Table 9. Ophthalmic AI-assisted Diagnosis Solution Industry Drivers Table 10. Ophthalmic AI-assisted Diagnosis Solution Industry Opportunities and Challenges Table 11. Ophthalmic AI-assisted Diagnosis Solution Industry Restraints Table 12. Global Ophthalmic AI-assisted Diagnosis Solution Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Ophthalmic AI-assisted Diagnosis Solution Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Ophthalmic AI-assisted Diagnosis Solution Market Share by Region (2021-2026) Table 15. Global Ophthalmic AI-assisted Diagnosis Solution Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Ophthalmic AI-assisted Diagnosis Solution Market Share by Region (2027-2032) Table 17. Global Ophthalmic AI-assisted Diagnosis Solution Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Ophthalmic AI-assisted Diagnosis Solution Revenue Market Share by Players (2021-2026) Table 19. Global Ophthalmic AI-assisted Diagnosis Solution Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Ophthalmic AI-assisted Diagnosis Solution Key Players Headquarters & Area Served Table 21. Global Ophthalmic AI-assisted Diagnosis Solution Players, Product Type & Application Table 22. Global Ophthalmic AI-assisted Diagnosis Solution Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Ophthalmic AI-assisted Diagnosis Solution by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Ophthalmic AI-assisted Diagnosis Solution Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Ophthalmic AI-assisted Diagnosis Solution Revenue Market Share by Type (2021-2026) Table 29. Global Ophthalmic AI-assisted Diagnosis Solution Revenue Market Share by Type (2027-2032) Table 30. Global Ophthalmic AI-assisted Diagnosis Solution Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Ophthalmic AI-assisted Diagnosis Solution Revenue Market Share by Application (2021-2026) Table 34. Global Ophthalmic AI-assisted Diagnosis Solution Revenue Market Share by Application (2027-2032) Table 35. Baidu Lingyi Company Information Table 36. Baidu Lingyi Business Overview Table 37. Baidu Lingyi Ophthalmic AI-assisted Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Baidu Lingyi Ophthalmic AI-assisted Diagnosis Solution Product Portfolio Table 39. Baidu Lingyi Recent Development Table 40. Tencent Health Company Information Table 41. Tencent Health Business Overview Table 42. Tencent Health Ophthalmic AI-assisted Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Tencent Health Ophthalmic AI-assisted Diagnosis Solution Product Portfolio Table 44. Tencent Health Recent Development Table 45. VoxelCloud Company Information Table 46. VoxelCloud Business Overview Table 47. VoxelCloud Ophthalmic AI-assisted Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. VoxelCloud Ophthalmic AI-assisted Diagnosis Solution Product Portfolio Table 49. VoxelCloud Recent Development Table 50. Wision Company Information Table 51. Wision Business Overview Table 52. Wision Ophthalmic AI-assisted Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Wision Ophthalmic AI-assisted Diagnosis Solution Product Portfolio Table 54. Wision Recent Development Table 55. ZHENHEALTH Company Information Table 56. ZHENHEALTH Business Overview Table 57. ZHENHEALTH Ophthalmic AI-assisted Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. ZHENHEALTH Ophthalmic AI-assisted Diagnosis Solution Product Portfolio Table 59. ZHENHEALTH Recent Development Table 60. Acer Medical Company Information Table 61. Acer Medical Business Overview Table 62. Acer Medical Ophthalmic AI-assisted Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Acer Medical Ophthalmic AI-assisted Diagnosis Solution Product Portfolio Table 64. Acer Medical Recent Development Table 65. IMLINCS Company Information Table 66. IMLINCS Business Overview Table 67. IMLINCS Ophthalmic AI-assisted Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. IMLINCS Ophthalmic AI-assisted Diagnosis Solution Product Portfolio Table 69. IMLINCS Recent Development Table 70. Vistel Company Information Table 71. Vistel Business Overview Table 72. Vistel Ophthalmic AI-assisted Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Vistel Ophthalmic AI-assisted Diagnosis Solution Product Portfolio Table 74. Vistel Recent Development Table 75. Airdoc Company Information Table 76. Airdoc Business Overview Table 77. Airdoc Ophthalmic AI-assisted Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Airdoc Ophthalmic AI-assisted Diagnosis Solution Product Portfolio Table 79. Airdoc Recent Development Table 80. Shenzhen SiSensing Company Information Table 81. Shenzhen SiSensing Business Overview Table 82. Shenzhen SiSensing Ophthalmic AI-assisted Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Shenzhen SiSensing Ophthalmic AI-assisted Diagnosis Solution Product Portfolio Table 84. Shenzhen SiSensing Recent Development Table 85. WeDoctor Company Information Table 86. WeDoctor Business Overview Table 87. WeDoctor Ophthalmic AI-assisted Diagnosis Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. WeDoctor Ophthalmic AI-assisted Diagnosis Solution Product Portfolio Table 89. WeDoctor Recent Development Table 90. Altris, Inc Company Information Table 91. Altris, Inc Business Overview Table 92. Altris, Inc Ophthalmic AI-assisted Diagnosis Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Altris, Inc Ophthalmic AI-assisted Diagnosis Solution Product Portfolio Table 94. Altris, Inc Recent Development Table 95. North America Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2021-2026) & (US$ Million) Table 96. North America Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2027-2032) & (US$ Million) Table 97. North America Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2021-2026) & (US$ Million) Table 98. North America Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2027-2032) & (US$ Million) Table 99. North America Ophthalmic AI-assisted Diagnosis Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Ophthalmic AI-assisted Diagnosis Solution Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Ophthalmic AI-assisted Diagnosis Solution Revenue by Country (US$ Million) & (2027-2032) Table 102. Europe Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2021-2026) & (US$ Million) Table 103. Europe Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2027-2032) & (US$ Million) Table 104. Europe Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2021-2026) & (US$ Million) Table 105. Europe Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2027-2032) & (US$ Million) Table 106. Europe Ophthalmic AI-assisted Diagnosis Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Ophthalmic AI-assisted Diagnosis Solution Revenue by Country (2021-2026) & (US$ Million) Table 108. Europe Ophthalmic AI-assisted Diagnosis Solution Revenue by Country (US$ Million) & (2027-2032) Table 109. China Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2021-2026) & (US$ Million) Table 110. China Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2027-2032) & (US$ Million) Table 111. China Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2021-2026) & (US$ Million) Table 112. China Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2021-2026) & (US$ Million) Table 114. Asia Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2027-2032) & (US$ Million) Table 115. Asia Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2021-2026) & (US$ Million) Table 116. Asia Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2027-2032) & (US$ Million) Table 117. Asia Ophthalmic AI-assisted Diagnosis Solution Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Asia Ophthalmic AI-assisted Diagnosis Solution Revenue by Region (US$ Million) & (2021-2026) Table 119. Asia Ophthalmic AI-assisted Diagnosis Solution Revenue by Region (US$ Million) & (2027-2032) Table 120. SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2021-2026) & (US$ Million) Table 121. SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2027-2032) & (US$ Million) Table 122. SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2021-2026) & (US$ Million) Table 123. SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2027-2032) & (US$ Million) Table 124. SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue by Country (2021-2026) & (US$ Million) Table 126. SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue by Country (US$ Million) & (2027-2032) Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Ophthalmic AI-assisted Diagnosis Solution Image Figure 2. Global Ophthalmic AI-assisted Diagnosis Solution Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ophthalmic AI-assisted Diagnosis Solution Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cloud-based Image Figure 5. On-Primes Image Figure 6. Global Ophthalmic AI-assisted Diagnosis Solution Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Ophthalmic AI-assisted Diagnosis Solution Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Imaging Center Image Figure 11. Global Ophthalmic AI-assisted Diagnosis Solution Market Size (US$ Million) & (2021-2032) Figure 12. Global Ophthalmic AI-assisted Diagnosis Solution Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Ophthalmic AI-assisted Diagnosis Solution Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Ophthalmic AI-assisted Diagnosis Solution Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Ophthalmic AI-assisted Diagnosis Solution Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Ophthalmic AI-assisted Diagnosis Solution Revenue Market Share by Type (2021-2032) Figure 19. Global Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Ophthalmic AI-assisted Diagnosis Solution Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Ophthalmic AI-assisted Diagnosis Solution Revenue Market Share by Application (2021-2032) Figure 22. North America Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Type (2021-2032) Figure 24. North America Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Application (2021-2032) Figure 25. North America Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Country (2021-2032) Figure 26. United States Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Type (2021-2032) Figure 31. Europe Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Application (2021-2032) Figure 32. Europe Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Country (2021-2032) Figure 33. Germany Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Type (2021-2032) Figure 43. China Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Application (2021-2032) Figure 44. Asia Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Type (2021-2032) Figure 46. Asia Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Application (2021-2032) Figure 47. Asia Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Region (2021-2032) Figure 48. Japan Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Type (2021-2032) Figure 56. SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Application (2021-2032) Figure 57. SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Country (2021-2032) Figure 58. Brazil Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Ophthalmic AI-assisted Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-Primes
Applications
  • Hospital
  • Clinic
  • Imaging Center
Companies covered
  • Baidu Lingyi
  • Tencent Health
  • VoxelCloud
  • Wision
  • ZHENHEALTH
  • Acer Medical
  • IMLINCS
  • Vistel
  • Airdoc
  • Shenzhen SiSensing
  • WeDoctor
  • Altris, Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ophthalmic AI-assisted Diagnosis Solution Market by Type
  3. 1.2.1 Global Ophthalmic AI-assisted Diagnosis Solution Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud-based
  5. 1.2.3 On-Primes
  6. 1.3 Ophthalmic AI-assisted Diagnosis Solution Market by Application
  7. 1.3.1 Global Ophthalmic AI-assisted Diagnosis Solution Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Imaging Center
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Ophthalmic AI-assisted Diagnosis Solution Market Dynamics
  1. 2.1 Ophthalmic AI-assisted Diagnosis Solution Industry Trends
  2. 2.2 Ophthalmic AI-assisted Diagnosis Solution Industry Drivers
  3. 2.3 Ophthalmic AI-assisted Diagnosis Solution Industry Opportunities and Challenges
  4. 2.4 Ophthalmic AI-assisted Diagnosis Solution Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Ophthalmic AI-assisted Diagnosis Solution Market Perspective (2021-2032)
  2. 3.2 Global Ophthalmic AI-assisted Diagnosis Solution Growth Trends by Region
  3. 3.2.1 Global Ophthalmic AI-assisted Diagnosis Solution Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ophthalmic AI-assisted Diagnosis Solution Market Size by Region (2021-2026)
  5. 3.2.3 Global Ophthalmic AI-assisted Diagnosis Solution Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Ophthalmic AI-assisted Diagnosis Solution Revenue by Players
  2. 4.1.1 Global Ophthalmic AI-assisted Diagnosis Solution Revenue by Players (2021-2026)
  3. 4.1.2 Global Ophthalmic AI-assisted Diagnosis Solution Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Ophthalmic AI-assisted Diagnosis Solution Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ophthalmic AI-assisted Diagnosis Solution Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Ophthalmic AI-assisted Diagnosis Solution Key Players Headquarters & Area Served
  7. 4.4 Global Ophthalmic AI-assisted Diagnosis Solution Players, Product Type & Application
  8. 4.5 Global Ophthalmic AI-assisted Diagnosis Solution Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Ophthalmic AI-assisted Diagnosis Solution Market CR5 and HHI
  11. 4.6.3 2025 Ophthalmic AI-assisted Diagnosis Solution Tier 1, Tier 2, and Tier 3
5 Ophthalmic AI-assisted Diagnosis Solution Market Size by Type
  1. 5.1 Global Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2021-2032)
  3. 5.3 Global Ophthalmic AI-assisted Diagnosis Solution Revenue Market Share by Type (2021-2032)
6 Ophthalmic AI-assisted Diagnosis Solution Market Size by Application
  1. 6.1 Global Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2021-2032)
  3. 6.3 Global Ophthalmic AI-assisted Diagnosis Solution Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Baidu Lingyi
  2. 7.1.1 Baidu Lingyi Company Information
  3. 7.1.2 Baidu Lingyi Business Overview
  4. 7.1.3 Baidu Lingyi Ophthalmic AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Baidu Lingyi Ophthalmic AI-assisted Diagnosis Solution Product Portfolio
  6. 7.1.5 Baidu Lingyi Recent Developments
  7. 7.2 Tencent Health
  8. 7.2.1 Tencent Health Company Information
  9. 7.2.2 Tencent Health Business Overview
  10. 7.2.3 Tencent Health Ophthalmic AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Tencent Health Ophthalmic AI-assisted Diagnosis Solution Product Portfolio
  12. 7.2.5 Tencent Health Recent Developments
  13. 7.3 VoxelCloud
  14. 7.3.1 VoxelCloud Company Information
  15. 7.3.2 VoxelCloud Business Overview
  16. 7.3.3 VoxelCloud Ophthalmic AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
  17. 7.3.4 VoxelCloud Ophthalmic AI-assisted Diagnosis Solution Product Portfolio
  18. 7.3.5 VoxelCloud Recent Developments
  19. 7.4 Wision
  20. 7.4.1 Wision Company Information
  21. 7.4.2 Wision Business Overview
  22. 7.4.3 Wision Ophthalmic AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Wision Ophthalmic AI-assisted Diagnosis Solution Product Portfolio
  24. 7.4.5 Wision Recent Developments
  25. 7.5 ZHENHEALTH
  26. 7.5.1 ZHENHEALTH Company Information
  27. 7.5.2 ZHENHEALTH Business Overview
  28. 7.5.3 ZHENHEALTH Ophthalmic AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
  29. 7.5.4 ZHENHEALTH Ophthalmic AI-assisted Diagnosis Solution Product Portfolio
  30. 7.5.5 ZHENHEALTH Recent Developments
  31. 7.6 Acer Medical
  32. 7.6.1 Acer Medical Company Information
  33. 7.6.2 Acer Medical Business Overview
  34. 7.6.3 Acer Medical Ophthalmic AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Acer Medical Ophthalmic AI-assisted Diagnosis Solution Product Portfolio
  36. 7.6.5 Acer Medical Recent Developments
  37. 7.7 IMLINCS
  38. 7.7.1 IMLINCS Company Information
  39. 7.7.2 IMLINCS Business Overview
  40. 7.7.3 IMLINCS Ophthalmic AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
  41. 7.7.4 IMLINCS Ophthalmic AI-assisted Diagnosis Solution Product Portfolio
  42. 7.7.5 IMLINCS Recent Developments
  43. 7.8 Vistel
  44. 7.8.1 Vistel Company Information
  45. 7.8.2 Vistel Business Overview
  46. 7.8.3 Vistel Ophthalmic AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Vistel Ophthalmic AI-assisted Diagnosis Solution Product Portfolio
  48. 7.8.5 Vistel Recent Developments
  49. 7.9 Airdoc
  50. 7.9.1 Airdoc Company Information
  51. 7.9.2 Airdoc Business Overview
  52. 7.9.3 Airdoc Ophthalmic AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Airdoc Ophthalmic AI-assisted Diagnosis Solution Product Portfolio
  54. 7.9.5 Airdoc Recent Developments
  55. 7.10 Shenzhen SiSensing
  56. 7.10.1 Shenzhen SiSensing Company Information
  57. 7.10.2 Shenzhen SiSensing Business Overview
  58. 7.10.3 Shenzhen SiSensing Ophthalmic AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Shenzhen SiSensing Ophthalmic AI-assisted Diagnosis Solution Product Portfolio
  60. 7.10.5 Shenzhen SiSensing Recent Developments
  61. 7.11 WeDoctor
  62. 7.11.1 WeDoctor Company Information
  63. 7.11.2 WeDoctor Business Overview
  64. 7.11.3 WeDoctor Ophthalmic AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
  65. 7.11.4 WeDoctor Ophthalmic AI-assisted Diagnosis Solution Product Portfolio
  66. 7.11.5 WeDoctor Recent Developments
  67. 7.12 Altris, Inc
  68. 7.12.1 Altris, Inc Company Information
  69. 7.12.2 Altris, Inc Business Overview
  70. 7.12.3 Altris, Inc Ophthalmic AI-assisted Diagnosis Solution Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Altris, Inc Ophthalmic AI-assisted Diagnosis Solution Product Portfolio
  72. 7.12.5 Altris, Inc Recent Developments
8 North America
  1. 8.1 North America Ophthalmic AI-assisted Diagnosis Solution Revenue (2021-2032)
  2. 8.2 North America Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2021-2032)
  3. 8.2.1 North America Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2021-2026)
  4. 8.2.2 North America Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2027-2032)
  5. 8.3 North America Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Type (2021-2032)
  6. 8.4 North America Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2021-2032)
  7. 8.4.1 North America Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2021-2026)
  8. 8.4.2 North America Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2027-2032)
  9. 8.5 North America Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Application (2021-2032)
  10. 8.6 North America Ophthalmic AI-assisted Diagnosis Solution Revenue by Country
  11. 8.6.1 North America Ophthalmic AI-assisted Diagnosis Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Ophthalmic AI-assisted Diagnosis Solution Revenue by Country (2021-2026)
  13. 8.6.3 North America Ophthalmic AI-assisted Diagnosis Solution Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Ophthalmic AI-assisted Diagnosis Solution Revenue (2021-2032)
  2. 9.2 Europe Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2021-2032)
  3. 9.2.1 Europe Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2021-2026)
  4. 9.2.2 Europe Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2027-2032)
  5. 9.3 Europe Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Type (2021-2032)
  6. 9.4 Europe Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2021-2032)
  7. 9.4.1 Europe Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2021-2026)
  8. 9.4.2 Europe Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2027-2032)
  9. 9.5 Europe Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Application (2021-2032)
  10. 9.6 Europe Ophthalmic AI-assisted Diagnosis Solution Revenue by Country
  11. 9.6.1 Europe Ophthalmic AI-assisted Diagnosis Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Ophthalmic AI-assisted Diagnosis Solution Revenue by Country (2021-2026)
  13. 9.6.3 Europe Ophthalmic AI-assisted Diagnosis Solution Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Ophthalmic AI-assisted Diagnosis Solution Revenue (2021-2032)
  2. 10.2 China Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2021-2032)
  3. 10.2.1 China Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2021-2026)
  4. 10.2.2 China Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2027-2032)
  5. 10.3 China Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Type (2021-2032)
  6. 10.4 China Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2021-2032)
  7. 10.4.1 China Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2021-2026)
  8. 10.4.2 China Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2027-2032)
  9. 10.5 China Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ophthalmic AI-assisted Diagnosis Solution Revenue (2021-2032)
  2. 11.2 Asia Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2021-2032)
  3. 11.2.1 Asia Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2021-2026)
  4. 11.2.2 Asia Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2027-2032)
  5. 11.3 Asia Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Type (2021-2032)
  6. 11.4 Asia Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2021-2032)
  7. 11.4.1 Asia Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2021-2026)
  8. 11.4.2 Asia Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2027-2032)
  9. 11.5 Asia Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Application (2021-2032)
  10. 11.6 Asia Ophthalmic AI-assisted Diagnosis Solution Revenue by Country
  11. 11.6.1 Asia Ophthalmic AI-assisted Diagnosis Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Ophthalmic AI-assisted Diagnosis Solution Revenue by Country (2021-2026)
  13. 11.6.3 Asia Ophthalmic AI-assisted Diagnosis Solution Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue (2021-2032)
  2. 12.2 SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue by Type (2027-2032)
  5. 12.3 SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue by Application (2027-2032)
  9. 12.5 SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue by Country
  11. 12.6.1 SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Ophthalmic AI-assisted Diagnosis Solution Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst